| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 30,864 | 29,993 | ||
| Investments | 104,639 | 112,836 | ||
| Prepaid expenses and other current assets | 3,489 | 3,897 | ||
| Total current assets | 138,992 | 146,726 | ||
| Property and equipment, net | 1,128 | 1,214 | ||
| Restricted cash | 827 | 824 | ||
| Right-of-use assets | 16,669 | 17,460 | ||
| Other non-current assets | 117 | 161 | ||
| Total assets | 157,733 | 166,385 | ||
| Accounts payable | 975 | 771 | ||
| Accrued expenses and other current liabilities | 14,570 | 16,034 | ||
| Total current liabilities | 15,545 | 16,805 | ||
| Non-current operating lease liabilities | 16,036 | 16,970 | ||
| Total liabilities | 31,581 | 33,775 | ||
| Common stock 0.0001 par value 500,000,000 shares authorized at september30, 2025 and december31, 2024 56,943,413 shares issued and outstanding at september30, 2025 and 56,644,655 shares issued and outstanding at december31, 2024 | 8 | 7 | ||
| Additional paid-in capital | 575,626 | 573,754 | ||
| Accumulated other comprehensive (loss) income | 142 | -25 | ||
| Accumulated deficit | -449,624 | -441,126 | ||
| Total stockholders' equity | 126,152 | 132,610 | ||
| Total liabilities and stockholders' equity | 157,733 | 166,385 | ||
Black Diamond Therapeutics, Inc. (BDTX)
Black Diamond Therapeutics, Inc. (BDTX)